Caricamento...
ANTIHYPERGLYCEMIC MEDICATION PRESCRIBING AND STATE MEDICAID PROGRAM RESPONSES TO ROSIGLITAZONE SAFETY WARNINGS
Medicaid programs use preferred drug lists to limit high-cost prescribing, but their effect on promoting more effective and safer prescribing is unknown. We examined the impact of the May 2007 rosiglitazone safety warnings on rosiglitazone availability on state Medicaid preferred drug list programs...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3319744/ https://ncbi.nlm.nih.gov/pubmed/22232110 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1377/hlthaff.2011.1068 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|